Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_assertion type Assertion NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_head.
- NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_assertion description "[Disease worsened in patients with SCA1, SCA2, and SCA3 mutations (mean [SE] increase in CCFSw, +0.014 [0.005] to +0.025 [0.004] per year), improved in patients with SPG4 mutations (mean [SE] increase in CCFSw, -0.012 [0.003] per year; P = .02), and remained stable in patients with SCA6, SCA7, or other SCA mutations (mean [SE] increase in CCFSw, -0.015 [0.011] to +0.009 [0.013] per year) or hereditary spastic paraplegia with other SPG mutations (mean [SE] increase in CCFSw, -0.005 [0.005] per year).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_provenance.
- NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_assertion evidence source_evidence_literature NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_provenance.
- NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_assertion SIO_000772 22491195 NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_provenance.
- NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_assertion wasDerivedFrom befree-20150227 NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_provenance.
- NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_assertion wasGeneratedBy ECO_0000203 NP710003.RA4M4AgyAxYz1hy3-WQqLTm3wVZdJ9_JMAgeO8C-x9VkU130_provenance.